Literature DB >> 11042224

Rational selection of antisense oligonucleotide sequences.

L Smith1, K B Andersen, L Hovgaard, J W Jaroszewski.   

Abstract

The purpose of this review is to identify rational selection procedures for the identification of optimal antisense oligonucleotide sequences. The review is firstly focused on how to find optimal hybridization sites, and secondly on how to select sequences that bind to structured RNA. The methods reviewed range from the more empirical testing of large numbers of mRNA complementary sequences to the more systematic techniques, i.e. RNase H mapping, use of combinatorial arrays and prediction of secondary structure of mRNA by computational methods. Structures that bind to structured RNA, i.e. aptastrucs and tethered oligonucleotide probes, and foldback triplex-forming oligonucleotides are also discussed. Relating to selection of antisense sequences by aid of computational analysis, valuable www addresses are given along with examples of folded structures of mRNA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042224     DOI: 10.1016/s0928-0987(00)00100-7

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  11 in total

1.  Multiplex PCR, amplicon size and hybridization efficiency on the NanoChip electronic microarray.

Authors:  Claus Børsting; Juan J Sanchez; Niels Morling
Journal:  Int J Legal Med       Date:  2004-01-14       Impact factor: 2.686

2.  Identification of genes involved in liver cancer cell growth using an antisense library of phage genomic DNA.

Authors:  Yun Han Lee; Young Ho Kim; Jong Gu Park
Journal:  Cancer Res Treat       Date:  2004-08-31       Impact factor: 4.679

3.  The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor.

Authors:  Paolo Ciana; Marta Fumagalli; Maria Letizia Trincavelli; Claudia Verderio; Patrizia Rosa; Davide Lecca; Silvia Ferrario; Chiara Parravicini; Valérie Capra; Paolo Gelosa; Uliano Guerrini; Silvia Belcredito; Mauro Cimino; Luigi Sironi; Elena Tremoli; G Enrico Rovati; Claudia Martini; Maria P Abbracchio
Journal:  EMBO J       Date:  2006-09-21       Impact factor: 11.598

4.  Thermodynamic and kinetic characterization of antisense oligodeoxynucleotide binding to a structured mRNA.

Authors:  S Patrick Walton; Gregory N Stephanopoulos; Martin L Yarmush; Charles M Roth
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

5.  Selection of optimal antisense accessible sites of survivin and its application in treatment of gastric cancer.

Authors:  Qiang-Song Tong; Li-Duan Zheng; Fang-Min Chen; Fu-Qing Zeng; Liang Wang; Ji-Hua Dong; Gong-Cheng Lu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

Review 6.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

7.  In vitro optimization of antisense oligodeoxynucleotide design: an example using the connexin gene family.

Authors:  Lee Yong Law; Wei V Zhang; N Susan Stott; David L Becker; Colin R Green
Journal:  J Biomol Tech       Date:  2006-09

8.  Secondary structure and hybridization accessibility of hepatitis C virus 3'-terminal sequences.

Authors:  Robert M Smith; Cherie M Walton; Catherine H Wu; George Y Wu
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 9.  Antisense oligonucleotides: the next frontier for treatment of neurological disorders.

Authors:  Carlo Rinaldi; Matthew J A Wood
Journal:  Nat Rev Neurol       Date:  2017-12-01       Impact factor: 42.937

10.  Identification and characterization of high affinity antisense PNAs for the human unr (upstream of N-ras) mRNA which is uniquely overexpressed in MCF-7 breast cancer cells.

Authors:  Huafeng Fang; Xuan Yue; Xiaoxu Li; John-Stephen Taylor
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.